1. Home
  2. WBX vs CRVO Comparison

WBX vs CRVO Comparison

Compare WBX & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$2.98

Market Cap

45.9M

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$4.31

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBX
CRVO
Founded
2015
2001
Country
Spain
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.9M
47.7M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
WBX
CRVO
Price
$2.98
$4.31
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$9.00
$21.50
AVG Volume (30 Days)
12.8K
88.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$9,737,974.00
Revenue This Year
N/A
N/A
Revenue Next Year
$37.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.29
52 Week Low
$0.23
$1.92
52 Week High
$7.83
$16.50

Technical Indicators

Market Signals
Indicator
WBX
CRVO
Relative Strength Index (RSI) 43.95 32.70
Support Level $2.84 N/A
Resistance Level $3.21 $5.44
Average True Range (ATR) 0.21 0.45
MACD -0.00 0.00
Stochastic Oscillator 25.84 22.96

Price Performance

Historical Comparison
WBX
CRVO

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: